
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New treatment options for delta virus: Is a cure in sight?
Cihan Yurdaydìn
Journal of Viral Hepatitis (2019) Vol. 26, Iss. 6, pp. 618-626
Closed Access | Times Cited: 35
Cihan Yurdaydìn
Journal of Viral Hepatitis (2019) Vol. 26, Iss. 6, pp. 618-626
Closed Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis
Alexander Stockdale, Benno Kreuels, Marc Henrion, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 523-532
Open Access | Times Cited: 487
Alexander Stockdale, Benno Kreuels, Marc Henrion, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 3, pp. 523-532
Open Access | Times Cited: 487
Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy
Mindie H. Nguyen, Grace Lai‐Hung Wong, Edward Gane, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 2
Open Access | Times Cited: 409
Mindie H. Nguyen, Grace Lai‐Hung Wong, Edward Gane, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 2
Open Access | Times Cited: 409
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 275
Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 275
EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
A review on hepatitis D: From virology to new therapies
Nathalie Mentha, Sophie Clément, Francesco Negro, et al.
Journal of Advanced Research (2019) Vol. 17, pp. 3-15
Open Access | Times Cited: 104
Nathalie Mentha, Sophie Clément, Francesco Negro, et al.
Journal of Advanced Research (2019) Vol. 17, pp. 3-15
Open Access | Times Cited: 104
A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis
Cihan Yurdaydìn, Onur Keskın, Esra Yurdcu, et al.
Hepatology (2021) Vol. 75, Iss. 6, pp. 1551-1565
Closed Access | Times Cited: 58
Cihan Yurdaydìn, Onur Keskın, Esra Yurdcu, et al.
Hepatology (2021) Vol. 75, Iss. 6, pp. 1551-1565
Closed Access | Times Cited: 58
Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies
Ivana Lazarević, Ana Banko, Danijela Miljanovic, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 46-46
Open Access | Times Cited: 8
Ivana Lazarević, Ana Banko, Danijela Miljanovic, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 46-46
Open Access | Times Cited: 8
STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters
Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 54
Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 54
Advances in hepatitis B therapeutics
Vincent Soriano, Pablo Barreiro, Edward R. Cachay, et al.
Therapeutic Advances in Infectious Disease (2020) Vol. 7
Open Access | Times Cited: 40
Vincent Soriano, Pablo Barreiro, Edward R. Cachay, et al.
Therapeutic Advances in Infectious Disease (2020) Vol. 7
Open Access | Times Cited: 40
Clinical effects of NTCP‐inhibitor myrcludex B
Dongliang Cheng, Bing Han, Wei Zhang, et al.
Journal of Viral Hepatitis (2021) Vol. 28, Iss. 6, pp. 852-858
Closed Access | Times Cited: 37
Dongliang Cheng, Bing Han, Wei Zhang, et al.
Journal of Viral Hepatitis (2021) Vol. 28, Iss. 6, pp. 852-858
Closed Access | Times Cited: 37
Chronic hepatitis delta: A state-of-the-art review and new therapies
Christy Gilman, Theo Heller, Christopher Koh
World Journal of Gastroenterology (2019) Vol. 25, Iss. 32, pp. 4580-4597
Open Access | Times Cited: 41
Christy Gilman, Theo Heller, Christopher Koh
World Journal of Gastroenterology (2019) Vol. 25, Iss. 32, pp. 4580-4597
Open Access | Times Cited: 41
Transporter Proteins as Therapeutic Drug Targets—With a Focus on SGLT2 Inhibitors
Nina Komaniecka, Sonia Maroszek, Maria Droździk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6926-6926
Open Access | Times Cited: 4
Nina Komaniecka, Sonia Maroszek, Maria Droździk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6926-6926
Open Access | Times Cited: 4
The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
Tomoyuki Hayashi, Yumie Takeshita, Yvan Hutin, et al.
Archives of Public Health (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 22
Tomoyuki Hayashi, Yumie Takeshita, Yvan Hutin, et al.
Archives of Public Health (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 22
Non‐invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta
Çağdaş Kalkan, Yusufcan Yılmaz, Beyza Doğanay Erdoğan, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 5, pp. 406-416
Closed Access | Times Cited: 8
Çağdaş Kalkan, Yusufcan Yılmaz, Beyza Doğanay Erdoğan, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 5, pp. 406-416
Closed Access | Times Cited: 8
The medical impact of hepatitis D virus infection in Uzbekistan
Malika Khodjaeva, Nargiz Ibadullaeva, Aziza Khikmatullaeva, et al.
Liver International (2019) Vol. 39, Iss. 11, pp. 2077-2081
Closed Access | Times Cited: 23
Malika Khodjaeva, Nargiz Ibadullaeva, Aziza Khikmatullaeva, et al.
Liver International (2019) Vol. 39, Iss. 11, pp. 2077-2081
Closed Access | Times Cited: 23
Targeting the Host for New Therapeutic Perspectives in Hepatitis D
Vincent Turon‐Lagot, Antonio Saviano, Catherine Schuster, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 222-222
Open Access | Times Cited: 18
Vincent Turon‐Lagot, Antonio Saviano, Catherine Schuster, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 222-222
Open Access | Times Cited: 18
Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts
Αfroditi Orfanidou, George Papatheodoridis, Εvangelos Cholongitas
Liver International (2021) Vol. 41, Iss. 7, pp. 1448-1461
Closed Access | Times Cited: 15
Αfroditi Orfanidou, George Papatheodoridis, Εvangelos Cholongitas
Liver International (2021) Vol. 41, Iss. 7, pp. 1448-1461
Closed Access | Times Cited: 15
The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappraisal
Mario Rizzetto, Saeed Hamid
Liver International (2020) Vol. 41, Iss. 1, pp. 16-19
Closed Access | Times Cited: 15
Mario Rizzetto, Saeed Hamid
Liver International (2020) Vol. 41, Iss. 1, pp. 16-19
Closed Access | Times Cited: 15
Will we need novel combinations to cure HBV infection?
Geoffrey Dusheiko
Liver International (2020) Vol. 40, Iss. S1, pp. 35-42
Closed Access | Times Cited: 14
Geoffrey Dusheiko
Liver International (2020) Vol. 40, Iss. S1, pp. 35-42
Closed Access | Times Cited: 14
Hepatitis B virus pre‐S region: Clinical implications and applications
Huizhen Sun, Le Chang, Ying Yan, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 4
Closed Access | Times Cited: 12
Huizhen Sun, Le Chang, Ying Yan, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 4
Closed Access | Times Cited: 12
Treatment endpoints for chronic hepatitis D
Olga Metin, Müjdat Zeybel, Cihan Yurdaydìn
Liver International (2022) Vol. 43, Iss. S1, pp. 60-68
Closed Access | Times Cited: 7
Olga Metin, Müjdat Zeybel, Cihan Yurdaydìn
Liver International (2022) Vol. 43, Iss. S1, pp. 60-68
Closed Access | Times Cited: 7
Current status of hepatitis delta
Μargarita Papatheodoridi, George Papatheodoridis
Current Opinion in Pharmacology (2021) Vol. 58, pp. 62-67
Closed Access | Times Cited: 8
Μargarita Papatheodoridi, George Papatheodoridis
Current Opinion in Pharmacology (2021) Vol. 58, pp. 62-67
Closed Access | Times Cited: 8
A Case Of Autoımmune Hepatitis Following Pegylated Interferon Treatment Of Chronic Hepatitis Delta
Feruze Yılmaz Enç
Northern Clinics of Istanbul (2019)
Open Access | Times Cited: 8
Feruze Yılmaz Enç
Northern Clinics of Istanbul (2019)
Open Access | Times Cited: 8
Hepatitis Delta Virus Infection: A Large Burden After All?
Cihan Yurdaydìn, Mehlika Toy
The Journal of Infectious Diseases (2019) Vol. 221, Iss. 10, pp. 1573-1575
Closed Access | Times Cited: 8
Cihan Yurdaydìn, Mehlika Toy
The Journal of Infectious Diseases (2019) Vol. 221, Iss. 10, pp. 1573-1575
Closed Access | Times Cited: 8
Present and future management of viral hepatitis
Rocío González Grande, Inmaculada Santaella Leiva, Susana López Ortega, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 47, pp. 8081-8102
Open Access | Times Cited: 6
Rocío González Grande, Inmaculada Santaella Leiva, Susana López Ortega, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 47, pp. 8081-8102
Open Access | Times Cited: 6